Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Pattern recognition/sensing molecules
- Identification of the NBD-LRR (NLR) family
- NLR protein family
- Members of the NLR gene family
- Diseases associated with NLR polymorphisms
- Function of NLR proteins (1)
- Study I: The multiple functions of NLRP3
- NLRP3 in IL-1 beta processing and inflammasome
- The NLR-based inflammasomes (1)
- Rare gain-of-function mutants of NLRP3 in CAPS
- Over-expression of NLRP3 leads to cell death
- Variant NLRP3-induced death is necrotic
- A model of pathogen-induced necrosis
- Reduced Shigella-induced cell death in NLRP3-/-
- Summary: NLRP3 and necrosis
- The NLR-based inflammasomes (2)
- ASC and NLRP3 in alum-induced response (1)
- ASC and NLRP3 in alum-induced response (2)
- NLRP3 in alum-induced IgE and IgG1 response
- NLRP3 and IL-1 beta inducing activity of adjuvants
- New functions of NLRP3
- Recombinant NLRP3 binds ATPgammaS
- Recombinant NLRP3 preferentially binds ATP/ADP
- WA mutation extinguishes ATP-binding activity
- Assembly with ASC depends on ATP-binding
- Inflammasome function depends on ATP-binding
- Study II: NLRX1 and type I IFN
- NLRX1 is predicted to localize to the mitochondria
- NLRX1 is found in the mitochondria
- Signaling pathway for detection of viral RNA
- NLRX1 localized in mitochondrial outer membrane
- NLRX1 interacts with MAVS/IPS/VISA/Cardif
- NLRX1 inhibits MAVS, RIG-I, and MDA-5 signaling
- NLRX1 siRNA upregulates MAVS-induced IFN-1
- NLRX1 inhibits RIG-I/MAVS interaction
- Summary: NLRX1
- The indirect recognition of PAM by NLR
- Function of NLR proteins (2)
- Acknowledgments
Topics Covered
- Pattern recognition/sensing molecules
- Identification of the NBD-LRR (NLR) family
- Autoimmune and Infectious Diseases associated with NLR polymorphisms/mutations
- Functions of NLR proteins
- The multiple functions of NLRP3
- The NLR-based inflammasomes
- Shigella flexneri
- NLRP3 and necrosis
- New functions of NLRP3
- NLRX1
- The indirect recognition of PAM by NLR
Talk Citation
Ting, J. (2009, July 6). NLR genes: infection, inflammation and vaccines [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/UYTL6152.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Jenny Ting has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.